The European Medicines Agency (EMA) Doubles User Licenses for TVT®, the Text Verification Tool®
Summary
For instance, EMA provides substantial fee discounts to distributors of parallel imports if their notifications are submitted with a TVT report. “The decision by EMA to double its number of licenses shows the strength of its commitment to our innovative TVT software,” said Frank Hessler, Managing Director of Schlafender Hase. It’s precisely during times of change that proven verification software is crucial in order to ensure the quality and accuracy of labelling and packaging.” As well as being used by EMA, TVT has been adopted by regulatory bodies such as Germany’s Federal Institute for Drugs and Medical Devices (BfArM), the Medicines & Healthcare products Regulatory Agency (MHRA) in the United Kingdom, and the Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM) in France. Schlafender Hase’s client base includes the world’s leading pharmaceutical and medical device companies, such as: Sanofi, Roche, Fresenius Kabi and Teva. Schlafender Hase is currently expanding its focus to bring the same time-saving and increased productivity benefits to pre-media and fast-moving consumer goods (FMCG) clients.
Classifications
AskAI Classifications
LabelsLinked Companies
